ZA972134B - Benzoxazepine compounds their production and use - Google Patents
Benzoxazepine compounds their production and useInfo
- Publication number
- ZA972134B ZA972134B ZA972134A ZA972134A ZA972134B ZA 972134 B ZA972134 B ZA 972134B ZA 972134 A ZA972134 A ZA 972134A ZA 972134 A ZA972134 A ZA 972134A ZA 972134 B ZA972134 B ZA 972134B
- Authority
- ZA
- South Africa
- Prior art keywords
- production
- benzoxazepine compounds
- benzoxazepine
- compounds
- Prior art date
Links
- ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical class O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU69442/96A AU6944296A (en) | 1995-09-13 | 1996-09-12 | Benzoxazepine compounds, their production and use as lipid lowering agents |
| JP24237896A JP3479796B2 (ja) | 1995-09-13 | 1996-09-12 | ベンゾオキサゼピン化合物 |
| PCT/JP1996/002596 WO1997010224A1 (fr) | 1995-09-13 | 1996-09-12 | Composes de benzoxazepine, leur production et leur utilisation en tant qu'agent d'abaissement des niveaux de lipides |
| EP96930365A EP0862562B1 (fr) | 1995-09-13 | 1996-09-12 | Composes de benzoxazepine, leur production et leur utilisation en tant qu'agent d'abaissement des niveaux de lipides |
| CN96196892A CN1072649C (zh) | 1995-09-13 | 1996-09-12 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| ZA972134A ZA972134B (en) | 1995-09-13 | 1997-03-12 | Benzoxazepine compounds their production and use |
| GR20010401564T GR3036707T3 (en) | 1995-09-13 | 2001-09-26 | Benzoxazepine compounds, their production and use as lipid lowering agents |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23545795 | 1995-09-13 | ||
| ZA972134A ZA972134B (en) | 1995-09-13 | 1997-03-12 | Benzoxazepine compounds their production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA972134B true ZA972134B (en) | 1999-06-30 |
Family
ID=26532138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA972134A ZA972134B (en) | 1995-09-13 | 1997-03-12 | Benzoxazepine compounds their production and use |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0862562B1 (fr) |
| CN (1) | CN1072649C (fr) |
| AU (1) | AU6944296A (fr) |
| GR (1) | GR3036707T3 (fr) |
| WO (1) | WO1997010224A1 (fr) |
| ZA (1) | ZA972134B (fr) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| WO1997048701A1 (fr) * | 1996-06-20 | 1997-12-24 | Pfizer Inc. | 4,1-benzoxazepines ou 4,1-benzothiazepines et leur utilisation comme inhibiteurs de squalene synthetase |
| WO1998047882A1 (fr) | 1997-04-21 | 1998-10-29 | Takeda Chemical Industries, Ltd. | 4,1 benzoxazepines, leurs analogues et leur utilisation comme agonistes de la somatostatine |
| JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
| AU1648001A (en) * | 1999-11-30 | 2001-06-12 | Takeda Chemical Industries Ltd. | Process for production of optically active benzhydrols |
| CZ20024151A3 (cs) * | 2000-06-23 | 2003-05-14 | Takeda Chemical Industries, Ltd. | Benzoxazepinony, způsob jejich výroby a použití |
| US20040063750A1 (en) * | 2000-11-09 | 2004-04-01 | Tomoyuki Nishimoto | High-density lipoprotein-cholesterol level elevating agent |
| US20040077689A1 (en) | 2001-04-25 | 2004-04-22 | Yasuo Sugiyama | Abc expression promoters |
| WO2003002147A1 (fr) * | 2001-06-28 | 2003-01-09 | Takeda Chemical Industries, Ltd. | Medicaments destines a la prevention/au traitement de troubles fonctionnels des organes et du dysfonctionnement des organes |
| EP1559422B1 (fr) | 2002-11-08 | 2014-04-30 | Takeda Pharmaceutical Company Limited | Agent de controle de la fonction recepteur |
| WO2004064865A1 (fr) * | 2003-01-17 | 2004-08-05 | Takeda Pharmaceutical Company Limited | Agent protecteur des muscles du squelette |
| US7625887B2 (en) | 2003-01-28 | 2009-12-01 | Takeda Pharmaceutical Company Limited | Receptor agonists |
| WO2004091628A1 (fr) * | 2003-04-18 | 2004-10-28 | Takeda Pharmaceutical Company Limited | Antagoniste de récepteur |
| RU2359661C2 (ru) | 2003-10-31 | 2009-06-27 | Такеда Фармасьютикал Компани Лимитед | Твердый препарат |
| EP1731505B1 (fr) | 2004-03-30 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Dérivés de l'acide alkoxyphénylpropanoïque |
| WO2006016681A2 (fr) * | 2004-08-09 | 2006-02-16 | Takeda Pharmaceutical Company Limited | Agent de reduction de la crp |
| EP2308839B1 (fr) | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Composés hétérocycliques condensés |
| EP1876179B1 (fr) | 2005-04-28 | 2015-03-25 | Takeda Pharmaceutical Company Limited | Composés de thiénopyrimidone |
| AR054368A1 (es) * | 2005-06-01 | 2007-06-20 | Takeda Pharmaceutical | Metodo para tratar hiperlipidemia |
| DK1897558T3 (da) | 2005-06-09 | 2013-12-09 | Norgine Bv | Fast præparat af 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-on |
| MY152185A (en) | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| BRPI0616077B8 (pt) | 2005-09-14 | 2021-05-25 | Takeda Pharmaceuticals Co | composição farmacêutica formulada em uma dose única, kit, artigo de manufatura, uso da composição farmacêutica e uso de um ou mais compostos antidiabéticos |
| JP5094416B2 (ja) | 2005-12-28 | 2012-12-12 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| JPWO2007119833A1 (ja) | 2006-04-14 | 2009-08-27 | 武田薬品工業株式会社 | 含窒素複素環化合物 |
| RS53230B (en) | 2006-06-27 | 2014-08-29 | Takeda Pharmaceutical Company Limited | CONDENSED CYCLICAL UNITS AS GPR40 RECEPTOR MODULATORS |
| EP2058309A4 (fr) | 2006-08-04 | 2010-12-22 | Takeda Pharmaceutical | Composé hétérocyclique à cycles fusionnés |
| US8492405B2 (en) | 2006-10-18 | 2013-07-23 | Takeda Pharmaceutical Company Limited | Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity |
| EP2074119A1 (fr) | 2006-10-19 | 2009-07-01 | Takeda Pharmaceutical Company Limited | Compose indole |
| US20100093777A1 (en) | 2007-01-25 | 2010-04-15 | Takeda Pharmaceutical Company Limited | Spiro-ring compound |
| JPWO2008102749A1 (ja) | 2007-02-20 | 2010-05-27 | 武田薬品工業株式会社 | 複素環化合物 |
| EP2149550A4 (fr) | 2007-04-27 | 2010-08-11 | Takeda Pharmaceutical | Composé hétérocyclique à cinq chaînons à teneur en azote |
| TW200914006A (en) | 2007-07-12 | 2009-04-01 | Takeda Pharmaceutical | Coated preparation |
| PE20140923A1 (es) | 2007-07-19 | 2014-08-11 | Takeda Pharmaceutical | Preparacion solida que comprende alogliptina y clorhidrato de metformina |
| US8586571B2 (en) | 2007-10-18 | 2013-11-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EP2210876B1 (fr) | 2007-11-01 | 2015-05-20 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique en tant qu'antagoniste de glucagon |
| UA100403C2 (en) | 2008-01-10 | 2012-12-25 | Такеда Фармасьютикал Компани Лимитед | Capsule formulation |
| US20110015225A1 (en) | 2008-04-01 | 2011-01-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JPWO2009128481A1 (ja) | 2008-04-16 | 2011-08-04 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| WO2010016552A1 (fr) | 2008-08-07 | 2010-02-11 | 武田薬品工業株式会社 | Agent thérapeutique pour le syndrome du côlon irritable |
| TW201014850A (en) | 2008-09-25 | 2010-04-16 | Takeda Pharmaceutical | Solid pharmaceutical composition |
| EP2351743A4 (fr) | 2008-10-27 | 2012-05-09 | Takeda Pharmaceutical | Composé bicyclique |
| EP2371826A4 (fr) | 2008-12-29 | 2012-06-27 | Takeda Pharmaceutical | Nouveau composé cyclique condensé et utilisation de celui-ci |
| JP2010254623A (ja) | 2009-04-24 | 2010-11-11 | Takeda Chem Ind Ltd | ベンゾオキサジノン化合物の結晶 |
| US20120172351A1 (en) | 2009-06-09 | 2012-07-05 | Nobuyuki Negoro | Novel fused cyclic compound and use thereof |
| JP5732394B2 (ja) | 2009-07-28 | 2015-06-10 | 武田薬品工業株式会社 | 錠剤 |
| WO2011041293A1 (fr) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Dérivés pyrazolo [1, 5a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose |
| DK2531501T3 (en) | 2010-02-03 | 2014-02-24 | Takeda Pharmaceutical | APOPTOSESIGNALREGULERENDE KINASE 1 inhibitors |
| BR112012027648A2 (pt) | 2010-04-27 | 2019-09-24 | Takeda Pharmaceuticals Co | composto medicamento, método para profilaxia ou tratamento de doença, e, uso de composto |
| BR112012032055B8 (pt) | 2010-06-16 | 2019-11-12 | Takeda Pharmaceuticals Co | cristal de cloridrato de 1-(4-metoxibutil)-n-(2-metilpropil)-n-[(3s,5r)-5-(morfolin-4-ilcarbonil)piperidin-3-il]-1h-benzimidazol-2-carboxamida, medicamento, e, uso do cristal |
| US20130184272A1 (en) | 2010-09-17 | 2013-07-18 | Takeda Pharmaceutical Company Limited | Diabetes therapeutic agent |
| JP2013209295A (ja) | 2010-10-13 | 2013-10-10 | Takeda Chem Ind Ltd | ペプチド誘導体 |
| US8729102B2 (en) | 2010-11-30 | 2014-05-20 | Takeda Pharmaceutical Company Limited | Bicyclic compound |
| MX2013009526A (es) | 2011-02-17 | 2013-10-01 | Takeda Pharmaceutical | Metodo de produccion de derivado de dihidrobenzofurano opticamente activo. |
| EP2772485A4 (fr) | 2011-10-24 | 2015-06-10 | Takeda Pharmaceutical | Composé bicyclique |
| JP6129850B2 (ja) | 2012-01-12 | 2017-05-17 | 武田薬品工業株式会社 | Ｍｃｈ受容体拮抗剤としてのベンゾイミダゾール誘導体 |
| US9181186B2 (en) | 2012-02-13 | 2015-11-10 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| JP6095580B2 (ja) | 2012-02-13 | 2017-03-15 | 武田薬品工業株式会社 | 芳香環化合物 |
| WO2013122260A1 (fr) | 2012-02-15 | 2013-08-22 | Takeda Pharmaceutical Company Limited | Comprimé |
| US9238639B2 (en) | 2012-02-24 | 2016-01-19 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| JPWO2013147026A1 (ja) | 2012-03-29 | 2015-12-14 | 武田薬品工業株式会社 | 芳香環化合物 |
| US9505772B2 (en) | 2012-05-10 | 2016-11-29 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| US9440987B2 (en) | 2012-05-10 | 2016-09-13 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| UY34847A (es) | 2012-06-05 | 2014-01-31 | Takeda Pharmaceutical | Preparacion sólida |
| EP2871179A4 (fr) | 2012-07-03 | 2016-03-16 | Ono Pharmaceutical Co | Composé ayant une activité agoniste sur un récepteur de la somatostatine, et leur utilisation à des fins médicales |
| JP2015127299A (ja) | 2012-07-19 | 2015-07-09 | 武田薬品工業株式会社 | 固形製剤 |
| EP2970331B1 (fr) | 2013-03-14 | 2017-05-17 | Takeda Pharmaceutical Company Limited | Dérivés de spiro azétidine isoxazole et leur utilisation en tant qu'antagonistes de sstr5 |
| WO2014165816A1 (fr) | 2013-04-05 | 2014-10-09 | North Carolina Central University | Composés utiles dans le traitement de troubles métaboliques et leur synthèse |
| CN105246512A (zh) | 2013-04-30 | 2016-01-13 | 艾伯维公司 | 使用阿曲生坦用于改善脂质概况的方法 |
| EP3019487A1 (fr) | 2013-07-09 | 2016-05-18 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique |
| JP6397410B2 (ja) | 2013-08-09 | 2018-09-26 | 武田薬品工業株式会社 | 芳香環化合物 |
| CN105593221B (zh) | 2013-09-30 | 2017-09-22 | 小野药品工业株式会社 | 具有生长抑素受体激动活性的化合物及其药物用途 |
| JO3442B1 (ar) | 2013-10-07 | 2019-10-20 | Takeda Pharmaceuticals Co | مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5) |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| BR112019016433A2 (pt) | 2017-02-08 | 2020-04-07 | Ono Pharmaceutical Co | composto que apresenta atividade agonística do receptor de somatostatina e uso farmacêutico do mesmo |
| AR111199A1 (es) | 2017-03-31 | 2019-06-12 | Takeda Pharmaceuticals Co | Compuesto aromático agonista de gpr40 |
| JOP20180028A1 (ar) | 2017-03-31 | 2019-01-30 | Takeda Pharmaceuticals Co | مركب ببتيد |
| WO2018181847A1 (fr) | 2017-03-31 | 2018-10-04 | 武田薬品工業株式会社 | Composé aromatique |
| KR20210008834A (ko) | 2018-03-23 | 2021-01-25 | 카모트 테라퓨틱스, 인크. | G-단백질 결합 수용체의 조절제 |
| AR116019A1 (es) | 2018-08-27 | 2021-03-25 | Scohia Pharma Inc | Derivados de guanidinobenzoilo como inhibidores de enteropeptidasa |
| JP2022503793A (ja) | 2018-09-24 | 2022-01-12 | 武田薬品工業株式会社 | Ｇｉｐ受容体アゴニストペプチド化合物及びその使用 |
| JP2022500483A (ja) | 2018-09-24 | 2022-01-04 | 武田薬品工業株式会社 | Ｇｉｐ受容体アゴニストペプチド化合物及びその使用 |
| AU2021241257A1 (en) | 2020-03-25 | 2022-10-13 | Takeda Pharmaceutical Company Limited | QD dosing of GIP receptor agonist peptide compounds and uses thereof |
| EP4126920A2 (fr) | 2020-03-25 | 2023-02-08 | Takeda Pharmaceutical Company Limited | Dosage d'une fois par semaine de composés peptidiques de l'agoniste du récepteur du gip et leurs utilisations |
| CR20230530A (es) | 2021-05-13 | 2024-02-19 | Carmot Therapeutics Inc | Moduladores de los receptores acoplados a proteínas g. |
| WO2023169456A1 (fr) | 2022-03-09 | 2023-09-14 | Gasherbrum Bio , Inc. | Agonistes hétérocycliques de glp-1 |
| WO2023179542A1 (fr) | 2022-03-21 | 2023-09-28 | Gasherbrum Bio , Inc. | Dérivés de 5,8-dihydro-1,7-naphtyridine utiles en tant qu'agonistes de glp-1 pour le traitement du diabète |
| WO2023198140A1 (fr) | 2022-04-14 | 2023-10-19 | Gasherbrum Bio, Inc. | Agonistes hétérocycliques de glp-1 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69332792T2 (de) * | 1992-04-20 | 2004-01-15 | Takeda Chemical Industries Ltd | 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| WO1995021834A1 (fr) * | 1994-02-09 | 1995-08-17 | Takeda Chemical Industries, Ltd. | Derives de 4,1-benzoxazepine a activite optique utilisables comme inhibiteurs de la synthase de squalene |
| TW401301B (en) * | 1994-10-07 | 2000-08-11 | Takeda Chemical Industries Ltd | Antihypertriglyceridemic composition |
| EP0710725A1 (fr) * | 1994-11-01 | 1996-05-08 | Takeda Chemical Industries, Ltd. | Production de composés optiquement actifs |
-
1996
- 1996-09-12 AU AU69442/96A patent/AU6944296A/en not_active Abandoned
- 1996-09-12 CN CN96196892A patent/CN1072649C/zh not_active Expired - Fee Related
- 1996-09-12 WO PCT/JP1996/002596 patent/WO1997010224A1/fr active IP Right Grant
- 1996-09-12 EP EP96930365A patent/EP0862562B1/fr not_active Expired - Lifetime
-
1997
- 1997-03-12 ZA ZA972134A patent/ZA972134B/xx unknown
-
2001
- 2001-09-26 GR GR20010401564T patent/GR3036707T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1072649C (zh) | 2001-10-10 |
| AU6944296A (en) | 1997-04-01 |
| EP0862562B1 (fr) | 2001-07-04 |
| EP0862562A1 (fr) | 1998-09-09 |
| GR3036707T3 (en) | 2001-12-31 |
| WO1997010224A1 (fr) | 1997-03-20 |
| CN1196052A (zh) | 1998-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA972134B (en) | Benzoxazepine compounds their production and use | |
| GB2298422B (en) | Compounds and their use | |
| IL123449A0 (en) | Toothbrush and its manufacture | |
| IL117631A0 (en) | Cyclic compounds their production and use | |
| IL118825A0 (en) | 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use | |
| IL119864A0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use | |
| EP0760220A3 (fr) | Brosse à dents | |
| TW351994U (en) | Diaper | |
| GB9505914D0 (en) | Toothbrush | |
| EG21140A (en) | Diaper | |
| GB2299499B (en) | Toothbrush | |
| IL118446A0 (en) | Triphenylalkyl antibacterial compounds and their preparation | |
| GB2297478B (en) | Toothbrush | |
| GB9504336D0 (en) | Diaper | |
| AU126652S (en) | Toothbrush | |
| GB9501009D0 (en) | Toothbrush | |
| GB9508637D0 (en) | New use | |
| GB9521912D0 (en) | Diaper | |
| ZA963484B (en) | New use | |
| SG69968A1 (en) | Cyclic compounds their production and use | |
| CA75683S (en) | Toothbrush | |
| CA76175S (en) | Toothbrush | |
| GB9510783D0 (en) | Clayware production | |
| GB9516136D0 (en) | New Use | |
| GB9520121D0 (en) | Use |